Lilly is the third company to partner with Sangamo on STAC-BBB after Astellas Gene Therapies, which paid $20 million upfront ...

Researchers suggest results could reignite interest in DLK inhibition as a treatment strategy for neurodegenerative diseases.

Praxis management will be presenting a corporate overview at the 24 th Annual Needham Virtual Healthcare Conference , taking place virtually on Monday, April 7, 2025 at 11:00a.m. EDT. A live webcast ...

Sangamo Therapeutics (SGMO) announced it has entered into a license agreement with Eli Lilly (LLY), allowing Lilly to leverage Sangamo’s novel ...

In mice, autism symptoms arise when a certain pair of competing nerve proteins falls out of equilibrium, according to a new study.

By influencing calcium homeostasis, local protein synthesis and the endoplasmic reticulum, a small protein called Rab10 emerges as a crucial cytoplasmic regulator of neuropeptide secretion.

Research identifies MDGA2- BDNF/TrkB-dependent mechanism that may point to therapeutic approaches for autism spectrum ...

Alzheimer’s disease, the most common cause of dementia, is currently incurable. The current drugs available have very limited ...

A new study reveals that autism-like symptoms in mice emerge when two nerve proteins—MDGA2 and BDNF—fall out of balance.

Reviewed by Lexie CornerApr 1 2025 Researchers at the Janelia Research Campus, Howard Hughes Medical Institute, have developed a new method to map changes in individual neuronal connections across the ...

If I’ve convinced you that self-similar networks manifest from the highest level of human organizations, down to the smallest ...

Adults with ADHD show changes such as higher iron accumulation in the brain — similar to early-stage dementia — which could ...